Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up

被引:25
|
作者
Yue, Han [1 ]
Qian, Jiang [1 ]
Yuan, Yifei [1 ]
Zhang, Rui [1 ]
Bi, Yingwen [2 ]
Meng, Fengxi [1 ]
Xuan, Yi [1 ]
机构
[1] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, 83 Fenyang Rd, Shanghai 200031, Peoples R China
[2] Fudan Univ, Dept Pathol, Eye & ENT Hosp, Shanghai, Peoples R China
关键词
BAP1; cancer; pathology; prognosis; uveal melanoma; CILIARY BODY; CHOROIDAL MELANOMA; BAP1; MUTATIONS; CANCER; DEATH;
D O I
10.1080/02713683.2016.1245422
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To summarize the clinicopathological characteristics and prognosis of uveal melanoma (UM) after enucleation in Chinese patients. Methods: Between 2003 and 2012, a series of 171 patients with UM received enucleation at the Eye & ENT Hospital of Fudan University in Shanghai. Patient clinical information was collected. Pathological examination and BAP1 staining of the enucleated eyes were conducted. Univariate and multivariate Cox proportional hazard regressions were conducted to determine the risk factors, and the survival rates were calculated and compared. Results: The study included 83 (49%) men and 88 (51%) women, with a mean age of 48.6 years. The mean largest basal tumor diameter and mean largest tumor thickness were 11.8 and 8.6 mm, respectively. Ciliary body involvement was observed in 19 tumors (11%). Spindle and nonspindle patterns were observed in 100 (58%) and 71 eyes (42%), respectively. Extrascleral extension was observed in three eyes (2%). BAP1 staining was negative in 34% (53/156) of all tumors and 53% (19/36) of the cases with melanoma-related metastasis. The mean follow-up period was 63.4 months for all patients with the exception of 11 patients, who were excluded because they were lost during follow-up. A large basal tumor diameter, ciliary body involvement, nonspindle cell type, extrascleral extension, and negative BAP1 staining were associated with a worse prognosis. The survival curves significantly differed between the BAP1-negative and BAP1-positive groups (P = 0.004). According to Kaplan-Meier analysis, the 5- and 10-year metastasis-free survival rates were 80% and 70%, respectively. Conclusions: A large basal tumor diameter, ciliary body involvement, nonspindle cell type, extrascleral extension, and negative BAP1 staining may be risk factors for the prediction of the UM prognosis. A younger age at diagnosis and a similar prognosis between genders may be unique features in Asian patients compared to the Caucasian population.
引用
收藏
页码:759 / 765
页数:7
相关论文
共 50 条
  • [1] Qualitiy of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment
    Klingenstein, A.
    Fuerweger, C.
    Muehlhofer, A. K.
    Leicht, S. F.
    Schaller, U. C.
    Muacevic, A.
    Wowra, B.
    Hintschich, C.
    Eibl, K. H.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (05) : 1005 - 1012
  • [2] Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up
    Wroblewska-Zierhoffer, Marta
    Paprzycka, Barbara
    Kubiak, Anna
    Tomczyk, Lukasz
    Rospond-Kubiak, Iwona
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [3] Uveal melanoma: Long-term survival
    Radivoyevitch, Tomas
    Zabor, Emily C.
    Singh, Arun D.
    PLOS ONE, 2021, 16 (05):
  • [4] Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment
    A. Klingenstein
    C. Fürweger
    A. K. Mühlhofer
    S. F. Leicht
    U. C. Schaller
    A. Muacevic
    B. Wowra
    C. Hintschich
    K. H. Eibl
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 1005 - 1012
  • [5] Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment
    Klingenstein, Annemarie
    Fuerweger, Christoph
    Nentwich, Martin M.
    Schaller, Ulrich C.
    Foerster, Paul I.
    Wowra, Berndt
    Muacevic, Alexander
    Eibl, Kirsten H.
    MELANOMA RESEARCH, 2013, 23 (06) : 481 - 488
  • [6] Clinicopathological characteristics, long-term prognosis and follow-up recommendations of primary and secondary cutaneous angiosarcoma: A Danish nationwide population-based cohort study
    Abebe, Kiya
    Wulff, Ida
    Thorsen, Katrine Voss
    Wagenblast, Anne Lene
    Schmidt, Grethe
    Jensen, David Hebbelstrup
    Holm, Christina Enciso
    Petersen, Michael M.
    Loya, Anand C.
    Mentzel, Thomas
    Herly, Mikkel
    Orholt, Mathias
    Vester-Glowinski, Peter
    EJSO, 2025, 51 (06):
  • [7] No Gender Differences in Long-Term Survival after Brachytherapy of 1,541 Patients with Uveal Melanoma
    Stalhammar, Gustav
    See, Thonnie Rose
    Fili, Maria
    Seregard, Stefan
    OCULAR ONCOLOGY AND PATHOLOGY, 2019, 5 (06) : 432 - 439
  • [8] Clinical determinants of long-term survival in metastatic uveal melanoma
    Koch, Elias A. T.
    Petzold, Anne
    Wessely, Anja
    Dippel, Edgar
    Erdmann, Michael
    Heinzerling, Lucie
    Hohberger, Bettina
    Knorr, Harald
    Leiter, Ulrike
    Meier, Friedegund
    Mohr, Peter
    Rahimi, Farnaz
    Schell, Beatrice
    Schlaak, Max
    Terheyden, Patrick
    Schuler-Thurner, Beatrice
    Ugurel, Selma
    Utikal, Jochen
    Vera, Julio
    Weichenthal, Michael
    Ziller, Fabian
    Berking, Carola
    Heppt, Markus, V
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1467 - 1477
  • [9] Long-term survival of uveal melanoma patients after surgery for liver metastases
    Frenkel, S.
    Nir, I.
    Hendler, K.
    Lotem, M.
    Eid, A.
    Jurim, O.
    Pe'er, J.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (08) : 1042 - 1046
  • [10] A single institute's experience on melanoma prognosis: a long-term follow-up
    Dika, Emi
    Chessa, Marco A.
    Veronesi, Giulia
    Ravaioli, Giulia M.
    Fanti, Pier A.
    Ribero, Simone
    Tripepi, Giovanni
    Gurioli, Carlotta
    Gradassi, Alessandro Traniello
    Lambertini, Martina
    Patrizi, Annalisa
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (03): : 326 - 332